1d
Zacks Investment Research on MSNRDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi BiosimilarDr. Reddy’s Laboratories RDY and China-based Bio-Thera Solutions announced that they have entered into commercialization and license agreements for BAT2206, a proposed biosimilar of Johnson & ...
Alvotech's 427% revenue surge in 2024—fueled by its biosimilar portfolio and global expansion—highlights the booming ...
It's been a mediocre week for Alvotech ( NASDAQ:ALVO ) shareholders, with the stock dropping 17% to US$9.55 in the ...
Alvotech (NASDAQ:ALVOW – Get Free Report) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 6,000 shares, a decline of 36.2% from ...
Stocks in the Nordic region dropped Friday, with the OMX Nordic 40 Index declining 1.0%. Alvotech posted the largest decline among large stocks during the session, plunging 11.4%, followed by ...
Northland Securities analyst Carl Byrnes maintained a Buy rating on Alvotech (ALVO – Research Report) today and set a price target of $28.00.
Learn more about whether Alvotech or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether Alvotech or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which ...
Wallenius Wilhelmsen ASA posted the largest decline among large stocks during the session, declining 8.8%, followed by Volvo Car AB Series B shares, which dropped 7.6%. Shares of Alvotech dropped 6.5% ...
Nkarta cuts 53 jobs, Felix Baker joins Bicycle board, Kelso gets £140M, Arbutus cuts 19 jobs, Ascletis shifts to obesity, ...
Alvotech (ALVO) announced the appointment of Balaji Prasad as chief strategy officer. He was most recently a director and equities analyst at ...
The Philippines joined the G7's commitment to upholding a free, open, prosperous and secure Indo-Pacific region, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results